Vascular Anomalies Caused by Abnormal Signaling within Endothelial Cells: Targets for Novel Therapies

Area of Science:

• Vascular biology and developmental biology.
• Molecular genetics and cell signaling.
• Oncology and therapeutic development.

Background:

• Vascular anomalies result from errors in blood vessel development and upkeep.
• Recent research highlights the role of intracellular signaling pathways in these anomalies.
• Endothelial cell dysfunction is a key feature, often driven by genetic mutations.

Purpose of the Study:

• To summarize recent breakthroughs in understanding the pathophysiology of vascular anomalies.
• To explore the potential of targeting hyperactivated signaling pathways for therapeutic intervention.
• To highlight a paradigm shift in treating developmental malformations.

Main Methods:

• Review of current literature on vascular anomaly pathogenesis.
• Analysis of the role of common intracellular signaling pathways.
• Investigation into the applicability of existing cancer therapeutics.

Main Results:

• Mutations frequently activate specific intracellular signaling pathways, leading to endothelial cell dysfunction.
• Two major signaling pathways are consistently hyperactivated in vascular anomalies.
• These pathways show promise for targeted therapy using molecular inhibitors.

Conclusions:

• Normalization of aberrant signaling pathways is a viable therapeutic strategy for vascular anomalies.
• This represents a significant shift from viewing developmental malformations as untreatable.
• Inhibitors developed for cancer treatment may be repurposed for vascular anomaly therapy.